Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural killer cells from patients relapsing on daratumumab therapy express an exhausted-associated phenotype. | Clin Hematol Int | 2026 | 42427930 | PubTator, text mining | PubMed |
| Nectin-4 as predictive biomarker of immune-related adverse event subtypes in adjuvant anti-programmed-death-1 treatment of melanoma. | Melanoma Res | 2026 | 42421561 | PubTator, text mining | PubMed |
| LFA-1 mechanical dose controls DNAM-1 signalling and perforin polarization in NK cells. | RSC Adv | 2026 | 42395744 | PubTator, text mining | PubMed |
| Identification of Bone Marrow and Peripheral Blood Plasma Extracellular Vesicle Protein Biomarker Signatures for Multiple Myeloma Diagnosis and Staging. | Int J Nanomedicine | 2026 | 42371508 | PubTator, text mining | PubMed |
| NKG2C + CD27 - Defines Human CD8 + Regulatory T Cells. | bioRxiv | 2026 | 42367888 | PubTator, text mining | PubMed |
| CD155 and its receptors in glioma: prospects for emerging immune checkpoint inhibitors. | Acta Neuropathol Commun | 2026 | 42174730 | PubTator, text mining | PubMed |
| Epithelial CD155-TIGIT/CD226 signaling links CD8⁺ T-cell exhaustion to frequent exacerbations in COPD. | Respir Res | 2026 | 42168982 | PubTator, text mining | PubMed |
| Expansion of NKG2A+CD8+ T cells with regulatory signatures distinguish individuals living with HIV-2 from those with HIV-1. | Med | 2026 | 42143018 | PubTator, text mining | PubMed |
| Natural killer cells in pediatric HIV cure strategies: from viral control to immunotherapeutics. | Curr Opin HIV AIDS | 2026 | 42139144 | PubTator, text mining | PubMed |
| A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms. | Signal Transduct Target Ther | 2026 | 42115611 | PubTator, text mining | PubMed |
| GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy. | Mol Cancer Ther | 2026 | 42083087 | PubTator, text mining | PubMed |
| Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors. | Cancer Immunol Immunother | 2026 | 42068384 | PubTator, text mining | PubMed |
| CD16+ γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection. | Gut | 2026 | 41986134 | PubTator, text mining | PubMed |
| Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy. | Cancer Res | 2026 | 41982126 | PubTator, text mining | PubMed |
| The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura. | Expert Rev Hematol | 2026 | 41948789 | PubTator, text mining | PubMed |
| Immune correlates underlying small fiber neuropathy presenting as vaccine-associated post-acute SARS- coronavirus syndrome. | Front Immunol | 2026 | 41939860 | PubTator, text mining | PubMed |
| Structure-Guided Engineering of TIGIT to Modulate Its Interaction With Nectin-4, a Tumour-Specific Antigen for the Development of Therapeutic Strategy. | Eur J Immunol | 2026 | 41928599 | PubTator, text mining | PubMed |
| Metformin drives HIF-1α-mediated dual metabolic reprogramming to enhance γδ T cell therapy in triple-negative breast cancer. | Cancer Immunol Immunother | 2026 | 41925872 | PubTator, text mining | PubMed |
| Regulatory T cells in axial spondyloarthritis. | Commun Biol | 2026 | 41917236 | PubTator, text mining | PubMed |
| Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy. | Ann Hematol | 2026 | 41915070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=2